In a significant development, the United States continues to assert its leadership in the North American Pediatric Vaccines Industry, maintaining a substantial market share of 17.9% throughout 2022. This milestone is underpinned by a robust enhancement of healthcare facilities across the country, opening up new avenues for the efficient distribution of pediatric vaccines. Simultaneously, there …